Dr. Andrew T. Jay
Dr. Andrew T. Jay
Dr. Andrew Jay is the Head of the HealthCare Fund at Siemens Venture Capital, which invests globally in imaging and diagnostic technologies. Since initiating the Fund in late 2002, his team has closed and exited multiple investments including BioImagene, Sequenom, USystems, and Zonare.

Dr. Jay previously was an I.I. ranked medical technology analyst for Deutsche Bank. He published over 10,000 pages of research on imaging, orthopedics, cardiovascular, vision, diabetes, diagnostics and neurologic devices. He was instrumental in raising over $2 billion in equity capital, and bringing over 20 companies public. He was frequently interviewed in the financial press including the Wall Street Journal, Investors Business Daily, CNN and MSNBC.

He has an MBA from the Kellogg School at Northwestern, a DMD from the University of Pennsylvania and a Bachelor of Science from Rensselaer Polytechnic Institute.

Outside of the office Andrew founded the Massachusetts Oyster Project, a non-profit that has re-introduced water cleansing oysters into Boston Harbor after an absence of 50 years. The organization can be found at www.massoyster.org.